1. Home
  2. TNGX vs TALKW Comparison

TNGX vs TALKW Comparison

Compare TNGX & TALKW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TNGX
  • TALKW
  • Stock Information
  • Founded
  • TNGX 2014
  • TALKW N/A
  • Country
  • TNGX United States
  • TALKW United States
  • Employees
  • TNGX N/A
  • TALKW 472
  • Industry
  • TNGX Biotechnology: Pharmaceutical Preparations
  • TALKW Medical/Nursing Services
  • Sector
  • TNGX Health Care
  • TALKW Health Care
  • Exchange
  • TNGX Nasdaq
  • TALKW Nasdaq
  • Market Cap
  • TNGX 735.0M
  • TALKW N/A
  • IPO Year
  • TNGX N/A
  • TALKW 2020
  • Fundamental
  • Price
  • TNGX $6.64
  • TALKW $0.17
  • Analyst Decision
  • TNGX Strong Buy
  • TALKW
  • Analyst Count
  • TNGX 8
  • TALKW 0
  • Target Price
  • TNGX $15.14
  • TALKW N/A
  • AVG Volume (30 Days)
  • TNGX 885.7K
  • TALKW N/A
  • Earning Date
  • TNGX 11-06-2024
  • TALKW N/A
  • Dividend Yield
  • TNGX N/A
  • TALKW N/A
  • EPS Growth
  • TNGX N/A
  • TALKW N/A
  • EPS
  • TNGX N/A
  • TALKW N/A
  • Revenue
  • TNGX $42,509,000.00
  • TALKW N/A
  • Revenue This Year
  • TNGX $18.15
  • TALKW N/A
  • Revenue Next Year
  • TNGX N/A
  • TALKW N/A
  • P/E Ratio
  • TNGX N/A
  • TALKW N/A
  • Revenue Growth
  • TNGX 26.16
  • TALKW N/A
  • 52 Week Low
  • TNGX $6.33
  • TALKW N/A
  • 52 Week High
  • TNGX $13.01
  • TALKW N/A
  • Technical
  • Relative Strength Index (RSI)
  • TNGX 37.15
  • TALKW N/A
  • Support Level
  • TNGX $6.83
  • TALKW N/A
  • Resistance Level
  • TNGX $7.47
  • TALKW N/A
  • Average True Range (ATR)
  • TNGX 0.37
  • TALKW 0.00
  • MACD
  • TNGX 0.11
  • TALKW 0.00
  • Stochastic Oscillator
  • TNGX 27.31
  • TALKW 0.00

About TNGX Tango Therapeutics Inc.

Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options.

About TALKW Talkspace Inc. Warrant

Talkspace Inc is a behavioral healthcare company offering access to licensed therapists, psychologists, and psychiatrists through its technology platform. It serves clients including health plans, enterprises, and individual subscribers. Therapists address various mental health conditions, while psychiatrists cater to a higher acuity demographic. Revenue primarily stems from payor and direct-to-enterprise clients, with contracts lasting one to three years. The majority of the Company's operations and revenues are based in the United States.

Share on Social Networks: